CD19 and pulmonary arterial hypertension: While previous studies have reported the dysregulation of regulatory T cells in PAH, our study uniquely focuses on the overexpression of the PD-1/PD-L1 on different lymphocyte subsets (CD4+, CD8+, and CD19+ cells) across multiple types of PAH.